These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33740905)

  • 1. The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study.
    de Vasconcellos K; Ramjathan P; Singh D
    BMC Infect Dis; 2021 Mar; 21(1):281. PubMed ID: 33740905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
    Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.
    Huerga H; Cossa L; Manhiça I; Bastard M; Telnov A; Molfino L; Sanchez-Padilla E
    Am J Trop Med Hyg; 2020 Mar; 102(3):562-566. PubMed ID: 31971152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
    Sigal GB; Pinter A; Lowary TL; Kawasaki M; Li A; Mathew A; Tsionsky M; Zheng RB; Plisova T; Shen K; Katsuragi K; Choudhary A; Honnen WJ; Nahid P; Denkinger CM; Broger T
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.
    Lawn SD
    BMC Infect Dis; 2012 Apr; 12():103. PubMed ID: 22536883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study.
    Daley P; Michael JS; Hmar P; Latha A; Chordia P; Mathai D; John KR; Pai M
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):989-95. PubMed ID: 19723379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
    Thit SS; Aung NM; Htet ZW; Boyd MA; Saw HA; Anstey NM; Kyi TT; Cooper DA; Kyi MM; Hanson J
    BMC Med; 2017 Aug; 15(1):145. PubMed ID: 28774293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies.
    Lawn SD; Dheda K; Kerkhoff AD; Peter JG; Dorman S; Boehme CC; Nicol MP
    BMC Infect Dis; 2013 Sep; 13():407. PubMed ID: 24004840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.
    Kerkhoff AD; Longley N; Kelly N; Cross A; Vogt M; Wood R; Hermans S; Lawn SD; Harrison TS
    BMC Infect Dis; 2020 Jul; 20(1):555. PubMed ID: 32736601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved algorithm for rapid diagnosis of pleural tuberculosis from pleural effusion by combined testing with GeneXpert MTB/RIF and an anti-LAM antibody-based assay.
    Liang Q; Pang Y; Yang Y; Li H; Guo C; Yang X; Chen X
    BMC Infect Dis; 2019 Jun; 19(1):548. PubMed ID: 31226940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
    García JI; Meléndez J; Álvarez R; Mejía-Chew C; Kelley HV; Sidiki S; Castillo A; Mazariegos C; López-Téllez C; Forno D; Ayala N; Balada-Llasat JM; Mejía-Villatoro CR; Wang SH; Torrelles JB; Ikeda J
    AIDS Res Ther; 2020 Oct; 17(1):62. PubMed ID: 33076996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
    BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk.
    García JI; Kelley HV; Meléndez J; de León RAA; Castillo A; Sidiki S; Yusoof KA; Nunes E; Téllez CL; Mejía-Villatoro CR; Ikeda J; García-Basteiro AL; Wang SH; Torrelles JB
    Sci Rep; 2019 Nov; 9(1):18012. PubMed ID: 31784649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care urine lipoarabinomannan antigen detection for diagnosis of tuberculosis in children.
    Gautam H; Singla M; Jain R; Lodha R; Kabra SK; Singh UB
    Int J Tuberc Lung Dis; 2019 Jun; 23(6):714-719. PubMed ID: 31315704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine.
    Hamasur B; Bruchfeld J; Haile M; Pawlowski A; Bjorvatn B; Källenius G; Svenson SB
    J Microbiol Methods; 2001 May; 45(1):41-52. PubMed ID: 11295196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania.
    Kroidl I; Clowes P; Reither K; Mtafya B; Rojas-Ponce G; Ntinginya EN; Kalomo M; Minja LT; Kowuor D; Saathoff E; Kroidl A; Heinrich N; Maboko L; Bates M; O'Grady J; Zumla A; Hoelscher M; Rachow A
    Eur Respir J; 2015 Sep; 46(3):761-70. PubMed ID: 26113682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.
    Qvist T; Johansen IS; Pressler T; Høiby N; Andersen AB; Katzenstein TL; Bjerrum S
    BMC Infect Dis; 2014 Dec; 14():655. PubMed ID: 25471640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.